In a significant and unexpected policy move, the federal government has opted to eliminate DRAP’s long-standing ability to set medicine pricing, marking a watershed moment in the country’s approach to pharmaceutical control. To this effect, the Ministry of Health has announced the formation of a new, specialised council dedicated entirely to deciding the cost of … Continue reading New drug pricing authority to replace DRAP